Atlas Trials

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Clinical trial NCT00123461 · COMPLETED

Trial details

NCT number
NCT00123461
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Secondary HyperparathyroidismRenal FailureChronic Renal Insufficiency
Start date
2005-07-01
Primary completion
2007-10-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.